CIL56(CA3)

  Cat. No.:  DC10839   Featured
Chemical Structure
300802-28-2
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
CIL56 is a small molecule that induces cellular ferroptosis through production of iron-dependent reactive oxygen species (ROS).
Cas No.: 300802-28-2
Chemical Name: 2,7-Bis(piperidin-1-ylsulfonyl)-9H-fluoren-9-one oxime
Synonyms: CIL56;CA3 - Bio-X;2,7-bis(piperidin-1-ylsulfonyl)-9H-fluoren-9-one oxime;CA3;ChemDiv1_019847;Oprea1_311942;Oprea1_120721;MLS000880133;CA3(CIL56);CIL 56;REGID_for_CID_654092;HMS643G03;HMS2386B14;BCP29111;s8661;SB19126;AK00779584;2,7-bis(piperidinosulfonyl)-9H-fluoren-9-one oxime;N-[(9E)-2,7-bis(piperidine-1-sulfonyl)-9H-fluoren-9-ylidene]hydroxylamine;CIL56(CA3)
SMILES: S(C1C([H])=C([H])C2=C(/C(/C3C([H])=C(C([H])=C([H])C2=3)S(N2C([H])([H])C([H])([H])C([H])([H])C([H])([H])C2([H])[H])(=O)=O)=N/O[H])C=1[H])(N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])(=O)=O
Formula: C23H27N3O5S2
M.Wt: 489.6076
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: CIL56 is a potent and selective ferroptosis inducer. Ferroptosis is an iron-dependent form of regulated cell death (RCD).
In Vitro: Ferroptosis is a non-apoptotic form of regulated cell death observed in cancer cells, kidney cells and neurons.CIL56 induces iron-dependent reactive oxygen species (ROS). Antioxidants and iron chelators only suppress the lethality of low concentrations of CIL56[1]. CIL56 triggers cell death dependent upon the rate-limiting de novo lipid synthetic enzyme ACC1.Using mass spectrometry, the metabolome of HT-1080 cells treated with CIL56 (6.5 μM)±TOFA (4 μM) is analyzed, compared to vehicle-treated controls. Among the 298 polar and nonpolar metabolites identified in this analysis, the levels of 141 metabolites are significantly altered by CIL56 treatment, with 82 metabolites significantly increased and 59 significantly decreased (FDR q<0.01). CIL56 triggers the striking TOFA-sensitive accumulation of all detectable long chain saturated and monounsaturated fatty acids and all detectable polyunsaturated fatty acids. A plausible model to account for the accumulation of both nonessential and essential fatty acids species is that CIL56 inhibits the normal breakdown of fatty acids by mitochondrial β-oxidation. CIL56 accelerates the ACC1-dependent production of malonyl-CoA, a metabolite that acts as a negative regulator of this process[2].
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
2018-0101
Cat. No. Product name Field of application
DC9746 RSL3 RSL3 is a ferroptosis activator in a VDAC-independent manner,exhibiting selectivity for tumor cells bearing oncogenic RAS.
DC7920 Liproxstatin-1 Liproxstatin-1 is able to suppress ferroptosis in cells, in Gpx4(-/-) mice, and in a pre-clinical model of ischaemia/reperfusion-induced hepatic damage.
DC10522 FIN56 FIN56 is a specific inducer of ferroptosis.
DC10742 Ferrostatin-1 (Fer-1) Ferrostatin-1 is a selective inhibitor of erastin induced ferroptosis with EC50 value of 60 nM.
DC10839 CIL56(CA3) CIL56 is a small molecule that induces cellular ferroptosis through production of iron-dependent reactive oxygen species (ROS).
X